One week later, the recipient mice were challenged with 5 × 103 PyWT i.v. None of the recipient mice developed a blood stage infection, i.e. the transfer of CD11c+-DC primed with γ-spz was sufficient to confer sterile protection against a sporozoite challenge (Fig 4A). Here, ITGAX is linked to infection.